Cold urticaria: inhibition of cold-induced histamine release by doxantrazole.
Thirteen patients with cold urticaria were studied to assess the effect of the systemic drug doxantrazole, which has actions resembling disodium cromoglycate, on cold evoked histamine release. The patients, all of whom developed an immediate local whealing response after cooling of the forearm, demonstrated release of histamine into venous blood draining that forearm. Following doxantrazole treatment, significant suppression of histamine release occurred. In some but not all patients this was accompanied by diminution of urtication in response to cooling. A double-blind study was carried out in 3 subjects, all of whom showed diminished cold-stimulated histamine release after doxantrazole. Two of these showed clinical improvement. Doxantrazole had no effect on erythema due to intradermal histamine, but did suppress the erythematous reaction to intradermal injection of compound 48/80. Our results suggest that doxantrazole or related anti-allergic agents might be useful in the treatment of cold urticaria.
D002648:Child; D002986:Clinical Trials as Topic; D003080:Cold Temperature / Q000009:adverse effects*; D004311:Double-Blind Method; D004341:Drug Evaluation; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use; D013892:Thioxanthenes / Q000494:pharmacology* / Q000627:therapeutic use; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology; D044004:Xanthones; D003189:p-Methoxy-N-methylphenethylamine / Q000037:antagonists & inhibitors
D013777:Tetrazoles; D013892:Thioxanthenes; D044004:Xanthones; D003189:p-Methoxy-N-methylphenethylamine; C010134:doxantrazole